Paul Tudor Jones’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Paul Tudor Jones’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-47,998	Closed	-$18K	–	1788
2016 Q3	$18K	Hold	47,998	–	–	﹤0.01%	1393
2016 Q2	$19K	Hold	47,998	–	–	﹤0.01%	1571
2016 Q1	$23K	Hold	47,998	–	–	﹤0.01%	1677
2015 Q4	$33K	Hold	47,998	–	–	﹤0.01%	1593
2015 Q3	$47K	Hold	47,998	–	–	﹤0.01%	1479
2015 Q2	$58K	Hold	47,998	–	–	﹤0.01%	1440
2015 Q1	$51K	Hold	47,998	–	–	﹤0.01%	1403
2014 Q4	$52K	Hold	47,998	–	–	﹤0.01%	1397
2014 Q3	$52K	Buy	47,998 +11,600	+32%	+$14.3K	﹤0.01%	1301
2014 Q2	$38K	Hold	36,398	–	–	﹤0.01%	1129
2014 Q1	$37K	Hold	36,398	–	–	﹤0.01%	1162
2013 Q4	$42K	Buy	+36,398	New	+$56.1K	﹤0.01%	1237

Other funds holding ENZN

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Paul Tudor Jones's ENZN Position: Q4 2016 in Review

Paul Tudor Jones sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2016, closing a stake of 47,998 shares — an estimated $18K sold.

Paul Tudor Jones first reported a position in ENZN in Q4 2013 and held it in 12 quarters. The position peaked at $58K in Q2 2015. 2 funds tracked by Wall St. Rank hold ENZN as of Q4 2016.

Paul Tudor Jones reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2016 after selling out during the quarter.
Paul Tudor Jones sold 47,998 ENZON PHARMACEUTICALS INC shares in Q4 2016, an estimated $18K.
Paul Tudor Jones first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 12 quarters.
Paul Tudor Jones's ENZON PHARMACEUTICALS INC position peaked at $58K in Q2 2015.
2 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.